Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Current Size And Growth Outlook For The Intravenous Solutions Market?

In the past few years, the market size for intravenous solutions has experienced significant growth. The market’s worth is projected to rise from $14 billion in 2024 to $14.91 billion in 2025, implying a compound annual growth rate (CAGR) of 6.5%. This historical growth can be traced back to several factors such as increase in surgical procedures, mounting cases of chronic diseases, the broadening scope of home healthcare, rigorous rules guaranteeing product safety, heightened emphasis on patient hydration, and worldwide emergency preparedness endeavors.

Anticipated robust expansion is on the horizon for the intravenous solutions market in the upcoming years, with its value projected to reach $20.1 billion in 2029, driven by a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this anticipated increase during the forecast period include a rise in population and aging demographics, a surge in surgical interventions, a heightened prevalence of infectious diseases, the implementation of telemedicine and remote patient monitoring, a focus on preventive healthcare, investments in global health security, and trends toward patient-centric care. Principal trends projected for this period incorporate a growing demand for parenteral nutrition solutions, increased usage of pre-mixed iv solutions, the expansion of home infusion therapies, the introduction of solutions balanced in electrolytes, the advent of innovative drug additives and adjuncts, and the integration of sophisticated iv systems for monitoring.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13465&type=smp

What Core Drivers Are Expected To Influence The Intravenous Solutions Market?

The escalating incidence of cancer is anticipated to spur the expansion of the intravenous solutions market. Cancer encompasses a series of illnesses characterized by unregulated cellular growth and the aptitude to encroach on adjoining tissues and distribute to different body sections. Intravenous solutions are regularly utilized in cancer care to administer chemotherapy medications and retain hydration throughout treatment. For example, in February 2024, the World Health Organization, an intergovernmental organization based in Switzerland, projected that by 2050, there would be over 35 million new cancer cases, which signifies a 77% growth compared to the estimated 20 million cases in 2022. Thus, the escalating prevalence of cancer is propelling the expansion of the intravenous solutions market.

Which Segmentation Categories Are Highlighted In The Intravenous Solutions Market Analysis?

The intravenous solutionsmarket covered in this report is segmented –

1) By Product: Total Parenteral Nutrition; Peripheral Parenteral Nutrition

2) By Nutrients: Carbohydrates; Vitamins And Minerals; Single Dose Amino Acids; Parenteral Lipid Emulsion; Other Nutrients

3) By Application: Basic Intravenous (IV) Solution; Nutritional Intravenous (IV) Solution; Blood Intravenous (IV) Solution; Drug Intravenous (IV) Solution; Irrigation Intravenous (IV) Solution

4) By End User: Hospitals; Clinics; Ambulatory Surgery Centers; Home Care Settings

Subsegments:

1) By Total Parenteral Nutrition (TPN): Carbohydrate Solutions; Amino Acid Solutions; Lipid Solutions; Electrolyte Solutions; Multivitamin Solutions

2) By Peripheral Parenteral Nutrition (PPN): Carbohydrate Solutions; Amino Acid Solutions; Lipid Solutions; Electrolyte Solutions

Which Market Trends Are Expected To Define The Future Of The Intravenous Solutions Market?

Leading corporations within the intravenous solutions market are concentrating on the creation of innovative syringe designs, such as pre-filled and ready-to-use types, in a bid to outdo competitors. These syringes are pre-packed with the required medication, negating the need for manual filling or arrangement, hence ready for immediate use. For example, in August 2023, GENIXUS Corp., a healthcare company based in the US, introduced the KinetiXTM Rocuronium Bromide Injection, available in 5mL and 10mL ready-to-administer (RTA) syringes. Designed from a clear, robust polymer material, these syringes overcome the potential hazards that might be presented by their glass counterparts. Filled and ready for use, they save time and minimize errors in medication dispensing. Rocuronium bromide injection is exclusively for intravenous application. This injection comes with some essential features, such as KitCheck-enabled by RFID, advanced kit and tray management technology, easily understandable labels, and a color-identified plunger rod for quick identification.

Who Are The Dominant Players In The Intravenous Solutions Market Today?

Major companies operating in the intravenous solutions market report are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Intravenous Solutions Market?

North America was the largest region in the intravenous solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13465&type=smp

Browse Through More Reports Similar to the Global Intravenous Solutions Market 2025, By The Business Research Company

Intravenous Infusion Pumps Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report

Intravenous Immunoglobulin Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report

Intravenous Iv Hydration Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intravenous-iv-hydration-therapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model